AI-assembled from public SEC filings

Restaurants and food-service operators peer review

Descriptive comparison assembled from public SEC filings and verified companyfacts.

Descriptive comparison — not investment advice. This feature-specific review is assembled from a frozen evidence pack of public SEC filing quotes and verified SEC companyfacts numbers. It is descriptive only and makes no judgment about which company is better. It is not a rating, recommendation, endorsement, forecast, or investment advice. Figures are as of their cited filing dates. See Disclaimer.

Methodology

The cluster is selected mechanically from public SEC SIC 5810 and 5812 companies already present in grepcent's processed universe, sorted by latest reported revenue. The set spans company-operated, franchised, casual-dining, coffee, and food-service models because those are how the SEC SIC pool is populated. The review publishes no proprietary index-membership labels.

Pack hash: eb67adb51c5cbf00436c6b6ce3f813de6afd515eee20f3a82acbbcf8720ff5d3. Generated: 2026-07-21.

Verified Quantitative Matrix

Numbers are templated from frozen SEC companyfacts-derived facts already verified by grepcent. Fiscal periods and filing dates are shown in each cell; code-computed comparisons below only use calendar-aligned periods.

Metric	SBUX	MCD	ARMK	DRI	CMG	YUM	TXRH	EAT	BLMN	CAKE	CBRL	WEN
Revenue	37,184,400,000 FY 2025; period end 2025-09-28; filed 2025-11-14; reporting currency USD source · NUM_SBUX_REVENUE_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	26,885,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source · NUM_MCD_REVENUE_FY2025	18,506,299,000 FY 2025; period end 2025-10-03; filed 2025-11-25; reporting currency USD source · NUM_ARMK_REVENUE_FY2025	12,076,700,000 FY 2025; period end 2025-05-25; filed 2025-07-18; reporting currency USD source · NUM_DRI_REVENUE_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	11,925,601,000 FY 2025; period end 2025-12-31; filed 2026-02-04; reporting currency USD source · NUM_CMG_REVENUE_FY2025	8,214,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source · NUM_YUM_REVENUE_FY2025	5,878,075,000 FY 2025; period end 2025-12-30; filed 2026-02-27; reporting currency USD source · NUM_TXRH_REVENUE_FY2025	5,384,200,000 FY 2025; period end 2025-06-25; filed 2025-08-15; reporting currency USD source · NUM_EAT_REVENUE_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	3,955,996,000 FY 2025; period end 2025-12-28; filed 2026-02-25; reporting currency USD source · NUM_BLMN_REVENUE_FY2025	3,751,806,000 FY 2025; period end 2025-12-30; filed 2026-02-23; reporting currency USD source · NUM_CAKE_REVENUE_FY2025	3,483,684,000 FY 2025; period end 2025-08-01; filed 2025-09-26; reporting currency USD source · NUM_CBRL_REVENUE_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	2,176,891,000 FY 2025; period end 2025-12-28; filed 2026-02-23; reporting currency USD source · NUM_WEN_REVENUE_FY2025
Net margin	4.99% FY 2025; period end 2025-09-28; filed 2025-11-14 source · NUM_SBUX_NET_MARGIN_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	31.85% FY 2025; period end 2025-12-31; filed 2026-02-24 source · NUM_MCD_NET_MARGIN_FY2025	1.76% FY 2025; period end 2025-10-03; filed 2025-11-25 source · NUM_ARMK_NET_MARGIN_FY2025	8.69% FY 2025; period end 2025-05-25; filed 2025-07-18 source · NUM_DRI_NET_MARGIN_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	12.88% FY 2025; period end 2025-12-31; filed 2026-02-04 source · NUM_CMG_NET_MARGIN_FY2025	18.98% FY 2025; period end 2025-12-31; filed 2026-02-20 source · NUM_YUM_NET_MARGIN_FY2025	7.05% FY 2025; period end 2025-12-30; filed 2026-02-27 source · NUM_TXRH_NET_MARGIN_FY2025	7.12% FY 2025; period end 2025-06-25; filed 2025-08-15 source · NUM_EAT_NET_MARGIN_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	0.21% FY 2025; period end 2025-12-28; filed 2026-02-25 source · NUM_BLMN_NET_MARGIN_FY2025	3.96% FY 2025; period end 2025-12-30; filed 2026-02-23 source · NUM_CAKE_NET_MARGIN_FY2025	1.33% FY 2025; period end 2025-08-01; filed 2025-09-26 source · NUM_CBRL_NET_MARGIN_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	7.58% FY 2025; period end 2025-12-28; filed 2026-02-23 source · NUM_WEN_NET_MARGIN_FY2025
Operating margin	7.90% FY 2025; period end 2025-09-28; filed 2025-11-14 source · NUM_SBUX_OPERATING_MARGIN_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	46.10% FY 2025; period end 2025-12-31; filed 2026-02-24 source · NUM_MCD_OPERATING_MARGIN_FY2025	4.28% FY 2025; period end 2025-10-03; filed 2025-11-25 source · NUM_ARMK_OPERATING_MARGIN_FY2025	11.28% FY 2025; period end 2025-05-25; filed 2025-07-18 source · NUM_DRI_OPERATING_MARGIN_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	16.23% FY 2025; period end 2025-12-31; filed 2026-02-04 source · NUM_CMG_OPERATING_MARGIN_FY2025	31.34% FY 2025; period end 2025-12-31; filed 2026-02-20 source · NUM_YUM_OPERATING_MARGIN_FY2025	8.08% FY 2025; period end 2025-12-30; filed 2026-02-27 source · NUM_TXRH_OPERATING_MARGIN_FY2025	9.51% FY 2025; period end 2025-06-25; filed 2025-08-15 source · NUM_EAT_OPERATING_MARGIN_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	0.94% FY 2025; period end 2025-12-28; filed 2026-02-25 source · NUM_BLMN_OPERATING_MARGIN_FY2025	4.99% FY 2025; period end 2025-12-30; filed 2026-02-23 source · NUM_CAKE_OPERATING_MARGIN_FY2025	1.58% FY 2025; period end 2025-08-01; filed 2025-09-26 source · NUM_CBRL_OPERATING_MARGIN_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	15.78% FY 2025; period end 2025-12-28; filed 2026-02-23 source · NUM_WEN_OPERATING_MARGIN_FY2025
Free cash flow	2,442,000,000 FY 2025; period end 2025-09-28; filed 2025-11-14; reporting currency USD source · NUM_SBUX_FREE_CASH_FLOW_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	7,186,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source · NUM_MCD_FREE_CASH_FLOW_FY2025	431,795,000 FY 2025; period end 2025-10-03; filed 2025-11-25; reporting currency USD source · NUM_ARMK_FREE_CASH_FLOW_FY2025	1,062,400,000 FY 2025; period end 2025-05-25; filed 2025-07-18; reporting currency USD source · NUM_DRI_FREE_CASH_FLOW_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	1,447,590,000 FY 2025; period end 2025-12-31; filed 2026-02-04; reporting currency USD source · NUM_CMG_FREE_CASH_FLOW_FY2025	1,639,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source · NUM_YUM_FREE_CASH_FLOW_FY2025	342,071,000 FY 2025; period end 2025-12-30; filed 2026-02-27; reporting currency USD source · NUM_TXRH_FREE_CASH_FLOW_FY2025	413,700,000 FY 2025; period end 2025-06-25; filed 2025-08-15; reporting currency USD source · NUM_EAT_FREE_CASH_FLOW_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	96,770,000 FY 2025; period end 2025-12-28; filed 2026-02-25; reporting currency USD source · NUM_BLMN_FREE_CASH_FLOW_FY2025	155,077,000 FY 2025; period end 2025-12-30; filed 2026-02-23; reporting currency USD source · NUM_CAKE_FREE_CASH_FLOW_FY2025	59,755,000 FY 2025; period end 2025-08-01; filed 2025-09-26; reporting currency USD source · NUM_CBRL_FREE_CASH_FLOW_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	242,616,000 FY 2025; period end 2025-12-28; filed 2026-02-23; reporting currency USD source · NUM_WEN_FREE_CASH_FLOW_FY2025
Capital expenditures	2,305,500,000 FY 2025; period end 2025-09-28; filed 2025-11-14; reporting currency USD source · NUM_SBUX_CAPEX_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	3,365,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source · NUM_MCD_CAPEX_FY2025	489,240,000 FY 2025; period end 2025-10-03; filed 2025-11-25; reporting currency USD source · NUM_ARMK_CAPEX_FY2025	644,600,000 FY 2025; period end 2025-05-25; filed 2025-07-18; reporting currency USD source · NUM_DRI_CAPEX_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	666,336,000 FY 2025; period end 2025-12-31; filed 2026-02-04; reporting currency USD source · NUM_CMG_CAPEX_FY2025	371,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source · NUM_YUM_CAPEX_FY2025	387,996,000 FY 2025; period end 2025-12-30; filed 2026-02-27; reporting currency USD source · NUM_TXRH_CAPEX_FY2025	265,300,000 FY 2025; period end 2025-06-25; filed 2025-08-15; reporting currency USD source · NUM_EAT_CAPEX_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	179,924,000 FY 2025; period end 2025-12-28; filed 2026-02-25; reporting currency USD source · NUM_BLMN_CAPEX_FY2025	146,204,000 FY 2025; period end 2025-12-30; filed 2026-02-23; reporting currency USD source · NUM_CAKE_CAPEX_FY2025	159,144,000 FY 2025; period end 2025-08-01; filed 2025-09-26; reporting currency USD source · NUM_CBRL_CAPEX_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	101,927,000 FY 2025; period end 2025-12-28; filed 2026-02-23; reporting currency USD source · NUM_WEN_CAPEX_FY2025
Dividends paid	2,771,400,000 FY 2025; period end 2025-09-28; filed 2025-11-14; reporting currency USD source · NUM_SBUX_DIVIDENDS_PAID_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	5,115,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source · NUM_MCD_DIVIDENDS_PAID_FY2025	110,821,000 FY 2025; period end 2025-10-03; filed 2025-11-25; reporting currency USD source · NUM_ARMK_DIVIDENDS_PAID_FY2025	658,500,000 FY 2025; period end 2025-05-25; filed 2025-07-18; reporting currency USD source · NUM_DRI_DIVIDENDS_PAID_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	Not available.	789,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source · NUM_YUM_DIVIDENDS_PAID_FY2025	180,262,000 FY 2025; period end 2025-12-30; filed 2026-02-27; reporting currency USD source · NUM_TXRH_DIVIDENDS_PAID_FY2025	0.00 FY 2025; period end 2025-06-25; filed 2025-08-15; reporting currency USD source · NUM_EAT_DIVIDENDS_PAID_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	38,266,000 FY 2025; period end 2025-12-28; filed 2026-02-25; reporting currency USD source · NUM_BLMN_DIVIDENDS_PAID_FY2025	52,192,000 FY 2025; period end 2025-12-30; filed 2026-02-23; reporting currency USD source · NUM_CAKE_DIVIDENDS_PAID_FY2025	23,098,000 FY 2025; period end 2025-08-01; filed 2025-09-26; reporting currency USD source · NUM_CBRL_DIVIDENDS_PAID_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	129,587,000 FY 2025; period end 2025-12-28; filed 2026-02-23; reporting currency USD source · NUM_WEN_DIVIDENDS_PAID_FY2025
Share buybacks	0.00 FY 2025; period end 2025-09-28; filed 2025-11-14; reporting currency USD source · NUM_SBUX_SHARE_BUYBACKS_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	2,056,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source · NUM_MCD_SHARE_BUYBACKS_FY2025	169,827,000 FY 2025; period end 2025-10-03; filed 2025-11-25; reporting currency USD source · NUM_ARMK_SHARE_BUYBACKS_FY2025	418,200,000 FY 2025; period end 2025-05-25; filed 2025-07-18; reporting currency USD source · NUM_DRI_SHARE_BUYBACKS_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	2,425,516,000 FY 2025; period end 2025-12-31; filed 2026-02-04; reporting currency USD source · NUM_CMG_SHARE_BUYBACKS_FY2025	552,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source · NUM_YUM_SHARE_BUYBACKS_FY2025	150,437,000 FY 2025; period end 2025-12-30; filed 2026-02-27; reporting currency USD source · NUM_TXRH_SHARE_BUYBACKS_FY2025	90,200,000 FY 2025; period end 2025-06-25; filed 2025-08-15; reporting currency USD source · NUM_EAT_SHARE_BUYBACKS_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	0.00 FY 2025; period end 2025-12-28; filed 2026-02-25; reporting currency USD source · NUM_BLMN_SHARE_BUYBACKS_FY2025	153,896,000 FY 2025; period end 2025-12-30; filed 2026-02-23; reporting currency USD source · NUM_CAKE_SHARE_BUYBACKS_FY2025	Not available.	200,766,000 FY 2025; period end 2025-12-28; filed 2026-02-23; reporting currency USD source · NUM_WEN_SHARE_BUYBACKS_FY2025
Assets	32,019,700,000 FY 2025; period end 2025-09-28; filed 2025-11-14; reporting currency USD source · NUM_SBUX_ASSETS_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	59,515,000,000 FY 2025; period end 2025-12-31; filed 2026-02-24; reporting currency USD source · NUM_MCD_ASSETS_FY2025	13,304,629,000 FY 2025; period end 2025-10-03; filed 2025-11-25; reporting currency USD source · NUM_ARMK_ASSETS_FY2025	12,587,000,000 FY 2025; period end 2025-05-25; filed 2025-07-18; reporting currency USD source · NUM_DRI_ASSETS_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	8,994,531,000 FY 2025; period end 2025-12-31; filed 2026-02-04; reporting currency USD source · NUM_CMG_ASSETS_FY2025	8,197,000,000 FY 2025; period end 2025-12-31; filed 2026-02-20; reporting currency USD source · NUM_YUM_ASSETS_FY2025	3,549,472,000 FY 2025; period end 2025-12-30; filed 2026-02-27; reporting currency USD source · NUM_TXRH_ASSETS_FY2025	2,678,600,000 FY 2025; period end 2025-06-25; filed 2025-08-15; reporting currency USD source · NUM_EAT_ASSETS_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	3,171,907,000 FY 2025; period end 2025-12-28; filed 2026-02-25; reporting currency USD source · NUM_BLMN_ASSETS_FY2025	3,261,672,000 FY 2025; period end 2025-12-30; filed 2026-02-23; reporting currency USD source · NUM_CAKE_ASSETS_FY2025	2,161,884,000 FY 2025; period end 2025-08-01; filed 2025-09-26; reporting currency USD source · NUM_CBRL_ASSETS_FY2025 Non-aligned period: 2025-Q3; row majority 2025-Q4.	4,956,561,000 FY 2025; period end 2025-12-28; filed 2026-02-23; reporting currency USD source · NUM_WEN_ASSETS_FY2025
Liabilities / equity	Not available.	Not available.	Not available.	4.45 FY 2025; period end 2025-05-25; filed 2025-07-18 source · NUM_DRI_LIABILITIES_TO_EQUITY_FY2025 Non-aligned period: 2025-Q2; row majority 2025-Q4.	2.18 FY 2025; period end 2025-12-31; filed 2026-02-04 source · NUM_CMG_LIABILITIES_TO_EQUITY_FY2025	Not available.	1.42 FY 2025; period end 2025-12-30; filed 2026-02-27 source · NUM_TXRH_LIABILITIES_TO_EQUITY_FY2025	Not available.	8.50 FY 2025; period end 2025-12-28; filed 2026-02-25 source · NUM_BLMN_LIABILITIES_TO_EQUITY_FY2025	6.47 FY 2025; period end 2025-12-30; filed 2026-02-23 source · NUM_CAKE_LIABILITIES_TO_EQUITY_FY2025	Not available.	41.23 FY 2025; period end 2025-12-28; filed 2026-02-23 source · NUM_WEN_LIABILITIES_TO_EQUITY_FY2025

Code-computed comparisons

Latest reported revenue range: range endpoints are WEN (2,176,891,000) and MCD (26,885,000,000). Calendar period: 2025-Q4. Computed from facts NUM_WEN_REVENUE_FY2025 and NUM_MCD_REVENUE_FY2025; no authored numeric comparison. Excluded from this comparison: CBRL: period not aligned (2025-Q3 vs 2025-Q4); DRI: period not aligned (2025-Q2 vs 2025-Q4); EAT: period not aligned (2025-Q2 vs 2025-Q4); SBUX: period not aligned (2025-Q3 vs 2025-Q4).
Reported net margin range: range endpoints are BLMN (0.21%) and MCD (31.85%). Calendar period: 2025-Q4. Computed from facts NUM_BLMN_NET_MARGIN_FY2025 and NUM_MCD_NET_MARGIN_FY2025; no authored numeric comparison. Excluded from this comparison: CBRL: period not aligned (2025-Q3 vs 2025-Q4); DRI: period not aligned (2025-Q2 vs 2025-Q4); EAT: period not aligned (2025-Q2 vs 2025-Q4); SBUX: period not aligned (2025-Q3 vs 2025-Q4).

Market-risk companion: risk and factor comparison from lmfin. It is descriptive and separate from the SEC fundamentals review.

Narrative Matrix

Dimension	SBUX	MCD	ARMK	DRI	CMG	YUM	TXRH	EAT	BLMN	CAKE	CBRL	WEN
Business model	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.
Geographic and customer exposure	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.
Capital allocation	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.
Stated strategy in filings	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.
Idiosyncratic risks in filings	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.
Recent narrative change	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.	Quarantined: no direct dimension-relevant quote survived the gate.

Gate summary

Facts: 100. Claims survived: 0. Claims dropped: 0. Cells quarantined: 72.

Quarantined quantitative rows

No quantitative metric rows quarantined.

Quarantined dimensions

business_model: No verified cells survived the gate.
geographic_customer_exposure: No verified cells survived the gate.
capital_allocation: No verified cells survived the gate.
stated_strategy: No verified cells survived the gate.
idiosyncratic_risks: No verified cells survived the gate.
recent_narrative_change: No verified cells survived the gate.

Quarantined cells

SBUX / business_model: No direct dimension-relevant quote survived the evidence gate.
MCD / business_model: No direct dimension-relevant quote survived the evidence gate.
ARMK / business_model: No direct dimension-relevant quote survived the evidence gate.
DRI / business_model: No direct dimension-relevant quote survived the evidence gate.
CMG / business_model: No direct dimension-relevant quote survived the evidence gate.
YUM / business_model: No direct dimension-relevant quote survived the evidence gate.
TXRH / business_model: No direct dimension-relevant quote survived the evidence gate.
EAT / business_model: No direct dimension-relevant quote survived the evidence gate.
BLMN / business_model: No direct dimension-relevant quote survived the evidence gate.
CAKE / business_model: No direct dimension-relevant quote survived the evidence gate.
CBRL / business_model: No direct dimension-relevant quote survived the evidence gate.
WEN / business_model: No direct dimension-relevant quote survived the evidence gate.
SBUX / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
MCD / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
ARMK / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
DRI / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
CMG / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
YUM / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
TXRH / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
EAT / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
BLMN / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
CAKE / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
CBRL / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.
WEN / geographic_customer_exposure: No direct dimension-relevant quote survived the evidence gate.